UniProt ID | EPHB1_HUMAN | |
---|---|---|
UniProt AC | P54762 | |
Protein Name | Ephrin type-B receptor 1 | |
Gene Name | EPHB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 984 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Early endosome membrane . Cell projection, dendrite . |
|
Protein Description | Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Cognate/functional ephrin ligands for this receptor include EFNB1, EFNB2 and EFNB3. During nervous system development, regulates retinal axon guidance redirecting ipsilaterally ventrotemporal retinal ganglion cells axons at the optic chiasm midline. This probably requires repulsive interaction with EFNB2. In the adult nervous system together with EFNB3, regulates chemotaxis, proliferation and polarity of the hippocampus neural progenitors. In addition to its role in axon guidance plays also an important redundant role with other ephrin-B receptors in development and maturation of dendritic spines and synapse formation. May also regulate angiogenesis. More generally, may play a role in targeted cell migration and adhesion. Upon activation by EFNB1 and probably other ephrin-B ligands activates the MAPK/ERK and the JNK signaling cascades to regulate cell migration and adhesion respectively. Involved in the maintenance of the pool of satellite cells (muscle stem cells) by promoting their self-renewal and reducing their activation and differentiation (By similarity).. | |
Protein Sequence | MALDYLLLLLLASAVAAMEETLMDTRTATAELGWTANPASGWEEVSGYDENLNTIRTYQVCNVFEPNQNNWLLTTFINRRGAHRIYTEMRFTVRDCSSLPNVPGSCKETFNLYYYETDSVIATKKSAFWSEAPYLKVDTIAADESFSQVDFGGRLMKVNTEVRSFGPLTRNGFYLAFQDYGACMSLLSVRVFFKKCPSIVQNFAVFPETMTGAESTSLVIARGTCIPNAEEVDVPIKLYCNGDGEWMVPIGRCTCKPGYEPENSVACKACPAGTFKASQEAEGCSHCPSNSRSPAEASPICTCRTGYYRADFDPPEVACTSVPSGPRNVISIVNETSIILEWHPPRETGGRDDVTYNIICKKCRADRRSCSRCDDNVEFVPRQLGLTECRVSISSLWAHTPYTFDIQAINGVSSKSPFPPQHVSVNITTNQAAPSTVPIMHQVSATMRSITLSWPQPEQPNGIILDYEIRYYEKEHNEFNSSMARSQTNTARIDGLRPGMVYVVQVRARTVAGYGKFSGKMCFQTLTDDDYKSELREQLPLIAGSAAAGVVFVVSLVAISIVCSRKRAYSKEAVYSDKLQHYSTGRGSPGMKIYIDPFTYEDPNEAVREFAKEIDVSFVKIEEVIGAGEFGEVYKGRLKLPGKREIYVAIKTLKAGYSEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAEMNYVHRDLAARNILVNSNLVCKVSDFGLSRYLQDDTSDPTYTSSLGGKIPVRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPMDCPAALHQLMLDCWQKDRNSRPRFAEIVNTLDKMIRNPASLKTVATITAVPSQPLLDRSIPDFTAFTTVDDWLSAIKMVQYRDSFLTAGFTSLQLVTQMTSEDLLRIGITLAGHQKKILNSIHSMRVQISQSPTAMA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MALDYLLLLLLA ---CHHHHHHHHHHH | 10.49 | 23663014 | |
13 | Phosphorylation | LLLLLLASAVAAMEE HHHHHHHHHHHHHHH | 24.20 | 23663014 | |
21 | Phosphorylation | AVAAMEETLMDTRTA HHHHHHHHHHCCCCC | 17.68 | 23663014 | |
25 | Phosphorylation | MEETLMDTRTATAEL HHHHHHCCCCCCEEC | 18.89 | 23663014 | |
57 | Phosphorylation | ENLNTIRTYQVCNVF CCCCCEEEEEEEECC | 17.92 | 24043423 | |
58 | Phosphorylation | NLNTIRTYQVCNVFE CCCCEEEEEEEECCC | 6.79 | 24043423 | |
92 | Phosphorylation | IYTEMRFTVRDCSSL EEEEEEEEEECHHHC | 12.31 | 24719451 | |
164 | Phosphorylation | KVNTEVRSFGPLTRN EECCCEECCCCCCCC | 39.47 | 27067055 | |
169 | Ubiquitination | VRSFGPLTRNGFYLA EECCCCCCCCEEEEE | 25.81 | 21987572 | |
169 | Phosphorylation | VRSFGPLTRNGFYLA EECCCCCCCCEEEEE | 25.81 | 27067055 | |
264 | Phosphorylation | PGYEPENSVACKACP CCCCCCCCEECEECC | 14.94 | 26074081 | |
285 | Phosphorylation | SQEAEGCSHCPSNSR CHHCCCCCCCCCCCC | 38.69 | 29083192 | |
289 | Phosphorylation | EGCSHCPSNSRSPAE CCCCCCCCCCCCCCC | 53.48 | 29083192 | |
291 | Phosphorylation | CSHCPSNSRSPAEAS CCCCCCCCCCCCCCC | 38.17 | 29083192 | |
334 | N-linked_Glycosylation | RNVISIVNETSIILE CCEEEEEECCEEEEE | 45.20 | UniProtKB CARBOHYD | |
395 | Phosphorylation | ECRVSISSLWAHTPY EEEEEEHHHHCCCCE | 26.68 | - | |
426 | N-linked_Glycosylation | PPQHVSVNITTNQAA CCCCEEEEEECCCCC | 20.55 | UniProtKB CARBOHYD | |
480 | N-linked_Glycosylation | EKEHNEFNSSMARSQ HHHHCCCCHHHHHHH | 27.31 | UniProtKB CARBOHYD | |
575 | Phosphorylation | AYSKEAVYSDKLQHY CCCCHHHHHCCCCCC | 20.42 | 20007894 | |
582 | Phosphorylation | YSDKLQHYSTGRGSP HHCCCCCCCCCCCCC | 8.58 | 30108239 | |
583 | Phosphorylation | SDKLQHYSTGRGSPG HCCCCCCCCCCCCCC | 23.43 | 30108239 | |
584 | Phosphorylation | DKLQHYSTGRGSPGM CCCCCCCCCCCCCCC | 24.59 | 29514088 | |
588 | Phosphorylation | HYSTGRGSPGMKIYI CCCCCCCCCCCEEEE | 19.54 | 30108239 | |
592 | Ubiquitination | GRGSPGMKIYIDPFT CCCCCCCEEEECCCC | 37.97 | - | |
594 | Phosphorylation | GSPGMKIYIDPFTYE CCCCCEEEECCCCCC | 8.18 | 21945579 | |
599 | Phosphorylation | KIYIDPFTYEDPNEA EEEECCCCCCCHHHH | 31.24 | 21945579 | |
600 | Phosphorylation | IYIDPFTYEDPNEAV EEECCCCCCCHHHHH | 20.79 | 21945579 | |
634 | Phosphorylation | AGEFGEVYKGRLKLP CCCCCCEECCCCCCC | 11.92 | 21082442 | |
643 | Ubiquitination | GRLKLPGKREIYVAI CCCCCCCCCEEEEEE | 44.94 | - | |
652 | Phosphorylation | EIYVAIKTLKAGYSE EEEEEEEHHHCCCCH | 27.64 | 26657352 | |
658 | Phosphorylation | KTLKAGYSEKQRRDF EHHHCCCCHHHHHHH | 37.08 | 26657352 | |
740 | Phosphorylation | KYLAEMNYVHRDLAA HHHHHCCCCCHHHHH | 9.05 | 20071362 | |
754 | Phosphorylation | ARNILVNSNLVCKVS HHCEEECCCEEEEEC | 24.86 | - | |
759 | Ubiquitination | VNSNLVCKVSDFGLS ECCCEEEEECCCCHH | 36.98 | 21987572 | |
761 | Phosphorylation | SNLVCKVSDFGLSRY CCEEEEECCCCHHHH | 16.83 | - | |
766 | Phosphorylation | KVSDFGLSRYLQDDT EECCCCHHHHCCCCC | 21.18 | 19369195 | |
768 | Phosphorylation | SDFGLSRYLQDDTSD CCCCHHHHCCCCCCC | 12.82 | 24927040 | |
773 | Phosphorylation | SRYLQDDTSDPTYTS HHHCCCCCCCCCEEC | 43.23 | 30108239 | |
774 | Phosphorylation | RYLQDDTSDPTYTSS HHCCCCCCCCCEECC | 48.89 | 28355574 | |
777 | Phosphorylation | QDDTSDPTYTSSLGG CCCCCCCCEECCCCC | 44.41 | 30108239 | |
778 | Phosphorylation | DDTSDPTYTSSLGGK CCCCCCCEECCCCCC | 15.26 | 15107421 | |
779 | Phosphorylation | DTSDPTYTSSLGGKI CCCCCCEECCCCCCC | 17.83 | 30108239 | |
780 | Phosphorylation | TSDPTYTSSLGGKIP CCCCCEECCCCCCCC | 17.10 | 30108239 | |
781 | Phosphorylation | SDPTYTSSLGGKIPV CCCCEECCCCCCCCC | 24.19 | 30108239 | |
791 | Ubiquitination | GKIPVRWTAPEAIAY CCCCCEEECCHHHHC | 23.05 | 21987572 | |
798 | Phosphorylation | TAPEAIAYRKFTSAS ECCHHHHCCCCCCHH | 14.28 | - | |
807 | Ubiquitination | KFTSASDVWSYGIVM CCCCHHHHHHHHEEE | 3.20 | 21987572 | |
813 | Ubiquitination | DVWSYGIVMWEVMSF HHHHHHEEEEEEECC | 2.95 | 21987572 | |
890 | Phosphorylation | RNPASLKTVATITAV CCHHHCCCEEEEEEC | 22.21 | 30108239 | |
893 | Phosphorylation | ASLKTVATITAVPSQ HHCCCEEEEEECCCC | 17.96 | 30108239 | |
895 | Phosphorylation | LKTVATITAVPSQPL CCCEEEEEECCCCCC | 19.76 | 30108239 | |
899 | Phosphorylation | ATITAVPSQPLLDRS EEEEECCCCCCCCCC | 37.52 | 30108239 | |
928 | Phosphorylation | SAIKMVQYRDSFLTA HHHHHHHCHHHHHHC | 12.65 | 15107421 | |
968 | Phosphorylation | HQKKILNSIHSMRVQ HHHHHHHHHHHHEEE | 20.45 | 18187866 | |
979 | Phosphorylation | MRVQISQSPTAMA-- HEEEECCCCCCCC-- | 19.89 | 18187866 | |
981 | Phosphorylation | VQISQSPTAMA---- EEECCCCCCCC---- | 34.02 | 18187866 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EPHB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPHB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PPAC_HUMAN | ACP1 | physical | 9499402 | |
GRB2_HUMAN | GRB2 | physical | 8798570 | |
GRB10_HUMAN | GRB10 | physical | 8798570 | |
NCK1_HUMAN | NCK1 | physical | 9430661 | |
CBL_HUMAN | CBL | physical | 18034775 | |
PTEN_HUMAN | PTEN | physical | 23118026 | |
NHRF1_HUMAN | SLC9A3R1 | physical | 23118026 | |
CBL_HUMAN | CBL | physical | 23118026 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-968, AND MASSSPECTROMETRY. |